Griffiths, C., Papp, K., Song, M., Miller, M., You, Y., Shen, Y.-K., Han, C. and Blauvelt, A. 2019. Maintenance of Response With up to 4 Years of Continuous Guselkumab Treatment: Results From the VOYAGE 1 Phase 3 Trial. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S17. DOI:https://doi.org/10.25251/skin.3.supp.17.